You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG-G-CSF

Showing 1 - 25 of 8,146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Localized Breast Cancer Trial in Dijon (Dense dose epirubicin-cyclophosphamide chemo and G-CSF (filgrastim, lenograstim), Dense

Not yet recruiting
  • Localized Breast Cancer
  • Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
  • Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
  • Dijon, Bourgogne, France
    Centre Georges François Leclerc (CGFL)
Mar 24, 2022

Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

Not yet recruiting
  • Granulocyte Colony-Stimulating Factor
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)

Recruiting
  • Granulocyte Colony-Stimulating Factor
  • PD-1 Inhibitor
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

PD-1 Inhibitor, G-CSF Trial in Guangzhou (Camrelizumab, G-CSF)

Recruiting
  • PD-1 Inhibitor
  • G-CSF
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

Recruiting
  • Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Aug 31, 2023

Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)

Recruiting
  • Retinoblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 25, 2022

Breast Cancer Female Trial in Shanghai (MW05, PEG-rhG-CSF)

Completed
  • Breast Cancer Female
  • Shanghai, China
    Fudan University Affiliated Cancer Hospital
Dec 1, 2022

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
Has Results
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))

Recruiting
  • Pediatric Cancer
  • +4 more
  • G-CSF administration (bolus injection versus intravenous infusion)
  • Taoyuan, ROC, Taiwan
    Chang Gung Children Hospital
Nov 21, 2023

Lymphoma Trial (PEG-rhG-CSF, rhG-CSF)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Dec 13, 2021

Alcoholic Hepatitis Trial in Chandigarh (Standard Medical Therapy, G-CSF, G-CSF and NAC)

Completed
  • Alcoholic Hepatitis
  • Standard Medical Therapy
  • +2 more
  • Chandigarh, India
    Dept of Hepatology, PGIMER
Apr 29, 2023

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

Recruiting
  • Secondary Acute Myeloid Leukemia Evolving From MDS
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 5, 2022

Lymphoma Trial in United States (Filgrastim, Pegfilgrastim, Rituximab)

Completed
Has Results
  • Lymphoma
  • Filgrastim
  • +6 more
  • Fort Smith, Arkansas
  • +6 more
Sep 22, 2020

Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)

Recruiting
  • Primary Ovarian Insufficiency
  • Premature Ovarian Failure
  • Toronto, Ontario, Canada
    Trio Fertility
Oct 31, 2023

Non-Myeloid Malignancy Trial in Beijing (YPEG-rhG-CSF, rhG-CSF/PEG-rhG-CSF)

Completed
  • Non-Myeloid Malignancy
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2022